Single-cell RNA Sequencing of Fluorescently Labeled Mouse Neurons Using Manual Sorting and Double In Vitro Transcription with Absolute Counts Sequencing (DIVA-Seq)
October 26th, 2018
8.8K views
This protocol describes the manual sorting procedure to isolate single fluorescently labeled neurons followed by in vitro transcription-based mRNA amplification for high-depth single-cell RNA sequencing.
Overview
This protocol details a manual sorting method for isolating single fluorescently labeled neurons, followed by in vitro transcription-based mRNA amplification to facilitate high-depth single-cell RNA sequencing. The aim is to overcome challenges in single-neuron isolation and sequencing by collecting specific neuronal populations from defined brain areas.
Key Study Components
Area of Science
- Neuroscience
- Cell biology
- Genomics
Background
- The method addresses challenges in isolating and sequencing single neurons.
- It focuses on collecting targeted neuronal populations without contamination.
- The approach is gentle and suitable for fragile neuron types.
- Single-cell RNA sequencing is gaining importance for understanding neuron function.
Purpose of Study
- To develop a method for reliable isolation of fluorescently labeled neurons.
- To enable high-depth RNA sequencing of individual neurons.
- To assess the genomic diversity and functionality of neuronal subpopulations.
Methods Used
- This protocol employs a manual sorting approach for neuron isolation from mouse brain slices.
- Fluorescently labeled GABAergic neurons from the cingulate cortex were specifically targeted.
- No multiomics workflow is used; the focus is on single-cell RNA sequencing.
- Key steps include preparing microcapillaries, dissecting the brain, and micro-dissecting sections.
- Single neurons were collected using capillary action and processed for RNA amplification.
Main Results
- Successfully isolated up to 150 neurons with minimized contamination.
- RNA from sorted neurons showed a peak distribution just above 500 base pairs, with sequencing yielding a high number of mapped reads.
- Demonstrated linearity in RNA input versus output, allowing for quantification of gene expression.
- Detected an average of 10,000 genes per neuron, with >95% of cells detecting >6,000 genes.
Conclusions
- This study enables precise isolation of specific neuronal subpopulations for RNA analysis.
- The findings can enhance our understanding of neuronal gene expression patterns.
- Implications include potential applications in neurobiology and disease models.
Frequently Asked Questions
What are the advantages of using this isolation method?
The method minimizes contamination and is gentle enough for fragile neurons, ensuring high viability and quality for downstream applications.
How is the brain tissue prepared for neuron isolation?
The brain is extracted from a euthanized mouse and sectioned into coronal or sagittal slices before isolating fluorescently labeled neurons.
What types of data are generated from this protocol?
The protocol allows for high-depth single-cell RNA sequencing data, providing insights into gene expression profiles of individual neurons.
Can this method be adapted for other types of neurons?
Yes, this technique can be adapted to isolate other neuron types as long as they are fluorescently labeled.
What are the limitations of this sorting technique?
The manual sorting process may be time-consuming and requires skilled handling to prevent damaging the neurons.
How can the findings from this study be applied?
The results can provide valuable insights into the molecular basis of neuronal behavior and plasticity, contributing to research in neurodegenerative diseases and brain function.
Executive Industry Relevance
Isolating rare, fluorescently labeled neuronal subpopulations remains a bottleneck in neuroscience target validation, particularly when conventional FACS is impractical due to low cell yields. This manual sorting approach enables high-purity collection of sparse neurons, supporting mechanistic de-risking in early discovery by preserving endogenous transcript ratios for accurate gene expression profiling. The resulting single-cell RNA-seq data enhances predictive confidence in target selection for neuropsychiatric and neurodegenerative disease models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in genetically defined neuronal subpopulations from user-defined brain areas.
- Operational Value: Provides a gentle isolation method compatible with fragile neuron types that do not survive conventional FACS pressures.
- Predictive Value: Preserves endogenous transcript ratios through double in vitro transcription amplification, supporting reliable biomarker discovery and pathway clarification.
Screening & Assay Development
- Scientific Value: Generates high-depth single-cell RNA-seq data with median 1.0×10⁵ unique reads per cell after UMI deduplication, enabling robust gene detection.
- Operational Value: Detects an average of 10,000 genes per neuron, with >95% of cells detecting >6,000 genes, ensuring transcriptome-wide coverage for assay validation.
- Scalability Value: Supports collection of 100–150 labeled neurons per experiment, providing sufficient replicates for statistical power in target engagement studies.
Translational & Preclinical Research
- Translational Value: Focuses on GABAergic neurons from the cingulate cortex, a disease-relevant system for neuropsychiatric disorder modeling.
- Mechanistic De-risking: Demonstrates linear input-to-observed counts relationship (slope 0.92, R² 0.94) using ERCC spike-ins, enabling absolute molecule quantification and reducing technical variability in preclinical validation.
- Continuity Value: Outputs size-restricted cDNA libraries (peak ~350 bp) compatible with downstream sequencing workflows, ensuring seamless transition from discovery to preclinical validation.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, specifically supporting target validation through molecular phenotyping of isolated neuronal subtypes prior to lead identification efforts.
- Discovery Biology: Supports hypothesis testing by enabling collection of specific neuronal populations from defined brain regions without contaminating debris.
- Screening: Produces quantitative, UMI-normalized mRNA counts that allow accurate comparison of gene expression across experimental conditions.
- Analytics: Generates absolute transcript counts via ERCC spike-in controls, facilitating cross-lab reproducibility and data integration in target prioritization.
- Translational Research: Aligns with disease-relevant systems by profiling cortical interneurons implicated in cognitive and affective disorder models.
- Enterprise Reuse: Establishes a standardized, reusable capability for isolating rare neuronal types across multiple projects, reducing dependency on specialized FACS infrastructure.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence by reducing mechanistic ambiguity in neuronal subtype-specific signaling pathways.
- Operational Value: Enhances reproducibility through standardized manual sorting and amplification protocols, minimizing batch effects in multi-site studies.
- Strategic Value: Improves go/no-go decision efficiency by providing early, human-relevant molecular insights into target engagement in rare cell populations.
- Portfolio Impact: Enables risk-adjusted advancement of targets based on quantitative, single-cell resolution data from disease-relevant neuronal circuits.
Implementation Considerations
- Requires expertise in manual microsurgery, fluorescent microscopy, and capillary-based cell handling under sterile conditions.
- Depends on specialized equipment including capillary pullers, vibratomes, fluorescent dissection scopes, and low-retention tubing systems.
- Necessitates standardization of ACSF composition, oxygenation protocols, and enzymatic digestion timing across operators to ensure consistency.
- Adaptation to other neuronal types relies on successful fluorescent labeling and may require optimization of dissection regions and protease concentrations.
- Practical limitations include lower throughput compared to FACS and dependence on operator skill to maintain cell viability during extended manual sorting sessions.
Biopharma FAQs
Why does UMI-based duplicate removal matter for target validation?
The protocol uses unique molecule identifiers to remove PCR duplicates, yielding median 1.0×10⁵ unique reads per cell. This ensures accurate quantification of gene expression, which is essential for reliable target validation in rare neuronal populations.
How does manual capillary sorting support discovery pipeline inputs?
Manual sorting via capillary action isolates single fluorescently labeled neurons with minimal debris contamination, providing high-purity input for downstream RNA amplification. This enables precise molecular profiling of defined neuronal subpopulations from specific brain areas.
What quantitative measurements enable preclinical target assessment?
The method generates absolute mRNA counts using ERCC spike-in controls, demonstrating a linear input-to-observed relationship (slope 0.92, R² 0.94). These quantitative outputs allow accurate comparison of gene expression changes in target engagement studies.
Why are replication requirements important for cross-functional collaboration?
The protocol supports collection of 100–150 neurons per experiment, providing sufficient biological replicates for statistical analysis. This reproducibility enables consistent data sharing between discovery, screening, and preclinical teams.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to analyze UMI-deduplicated read counts and assess linearity using spike-in controls, as demonstrated by the observed slope of 0.92 and adjusted R² of 0.94. These capabilities ensure data quality and comparability across experiments.
